Newron Pharmaceuticals S.p.A. | WebDisclosure

Basculer en Français

8227	Companies
111057	Keywords
52775	Articles
60952	Press releases

Headlines Articles Press releases Newron Pharmaceuticals S.p.A.

Home
Companies
Newron Pharmaceuticals S.p.A.

PRESS RELEASE

published on 10/09/2023 at 12:45, 1 year ago

Newron TRS study 6 months’ results: Evenamide substantially improves patients to an extent that they no longer meet protocol entry criteria
PRESS RELEASE

published on 10/04/2023 at 07:00, 1 year 1 month ago

Newron to present three posters on its clinical program evaluating evenamide in the treatment of schizophrenia at the 36th European College of Neuropsychopharmacology Congress
PRESS RELEASE

published on 10/02/2023 at 07:00, 1 year 1 month ago

Newron appoints Margarita Chavez as board advisor
PRESS RELEASE

published on 08/04/2023 at 07:00, 1 year 3 months ago

Newron announces H1 2023 results and provides R&D update
PRESS RELEASE

published on 05/15/2023 at 07:00, 1 year 5 months ago

Newron presents exciting new data from study 014/015 at CINP World Congress of Neuropsychopharmacology and the 2023 Congress of the Schizophrenia International Research Society (SIRS)
PRESS RELEASE

published on 05/03/2023 at 07:00, 1 year 6 months ago

Newron to present at the 34th CINP World Congress of Neuropsychopharmacology and the 2023 Congress of the Schizophrenia International Research Society (SIRS)
PRESS RELEASE

published on 05/02/2023 at 07:00, 1 year 6 months ago

Newron announces Senior Management Team changes
PRESS RELEASE

published on 04/18/2023 at 12:15, 1 year 6 months ago

Newron announces AGM 2023 results
PRESS RELEASE

published on 03/28/2023 at 12:30, 1 year 7 months ago

Newron presents six-month interim data from the first 100 patients randomized in study 014/015 at the 31st European Congress of Psychiatry
PRESS RELEASE

published on 03/20/2023 at 07:00, 1 year 7 months ago

Newron reports compelling topline results from all patients in Study 014, its Phase II clinical trial evaluating evenamide as add-on therapy for treatment-resistant schizophrenia

Accesswire

Published on 11/08/2024 at 13:05, 8 minutes ago

Aton Announces Corporate and Operations Update
Published on 11/08/2024 at 13:00, 13 minutes ago

Honey Badger Announces Change of Transfer Agent
Published on 11/08/2024 at 13:00, 13 minutes ago

NioCorp Provides Preliminary Financial Results for the Three Months Ended September 30, 2024
Published on 11/08/2024 at 13:00, 13 minutes ago

Velocity One Signs Merger Agreement With EMCORE (EMKR)
Published on 11/08/2024 at 12:30, 43 minutes ago

Jaguar Mining Reports Financial Results for the Third Quarter 2024

View all ACCESSWIRE

EQS Group

Published on 11/08/2024 at 12:31, 42 minutes ago

Original-Research: ORBIS SE (von GSC Research GmbH): Kaufen
Published on 11/08/2024 at 12:30, 43 minutes ago

Holding(s) in Company
Published on 11/08/2024 at 12:25, 48 minutes ago

freenet Executive Board formulates financial ambition until 2028 - EBITDA and free cash flow to grow significantly
Published on 11/08/2024 at 12:11, 1 hour 2 minutes ago

PNE AG selected by the European Commission for funding a project to produce hydrogen
Published on 11/08/2024 at 12:01, 1 hour 11 minutes ago

EQS-Adhoc: Borussia Dortmund reports preliminary figures for the first quarter (Q1) of the 2024/2025 financial year

Les Echos

Published on 11/08/2024 at 12:32, 41 minutes ago

Louis Hachette Group announces the publication of its Information Document for listing on Euronext Growth (Paris)
Published on 11/08/2024 at 12:32, 41 minutes ago

Louis Hachette Group annonce la publication de son Document d’Information en vue de sa cotation sur Euronext Growth (Paris)
Published on 11/08/2024 at 12:15, 58 minutes ago

Louis Hachette Group announces the publication of its Information Document for listing on Euronext Growth (Paris)
Published on 11/08/2024 at 12:15, 58 minutes ago

Louis Hachette Group annonce la publication de son Document d’Information en vue de sa cotation sur Euronext Growth (Paris)
Published on 11/08/2024 at 08:00, 5 hours 13 minutes ago

DAMARTEX / Droits de vote bruts et réels 31 octobre 2024

View all LES ECHOS COMFI WIRE